Dr. Reddy's Laboratories Ltd. has launched Bivalirudin for Injection, 250 mg/vial, a therapeutic equivalent generic version of Angiomax (Bivalirudin) for injection, approved by the USFDA. 250 mg/vial injection is available in packages of 10 single-dose vials.